Colominic acid (CA) is an a2,8-linked polymer of sialic acid, originally isolated from capsular Escherichia coli K1. 2) have several biological activities including antiviral activities, [3] [4] [5] inhibition of the cytotoxic action of bee and snake venom, 6) inhibition of P-selectin-dependent macrophage infiltration in the glomeruli in experimental rat crescentic glomerulonephritis 7) and inhibition of fertilization of mouse gametes.
Sulfated CA (SCA), prepared by the chemical sulfation of CA, 2) have several biological activities including antiviral activities, [3] [4] [5] inhibition of the cytotoxic action of bee and snake venom, 6) inhibition of P-selectin-dependent macrophage infiltration in the glomeruli in experimental rat crescentic glomerulonephritis 7) and inhibition of fertilization of mouse gametes. 8) Atherosclerosis is the principal vascular lesion in the pathogenesis of myocardial and cerebral infarction, which is initiated by vascular endothelial cell damage followed by an intimal hyperplasia of vascular smooth muscle cells. 9) Although the pathogenesis of atherosclerosis is not simple, inhibition of arterial smooth muscle cell proliferation is one of the effective strategies to prevent atherosclerosis.
We have investigated the effects of sodium spirulan (Na-SP), a sulfated polysaccharide isolated from the blue-green alga Spirulina platensis 10) on vascular endothelial and smooth muscle cell functions, and found that the polysaccharide potently inhibits the proliferation of vascular smooth muscle cells. 11) In vascular endothelial cells, Na-SP elevates the fibrinolytic activity of vascular endothelial cells through inhibition of the secretion of plasminogen activator inhibitor type 1. 12) In addition, Na-SP promotes the secretion of anticoagulant proteoglycans 13) such as perlecan and biglycan, 14) as well as exhibiting an antithrombin activity through activation of heparin cofactor II. 15, 16) We hypothesized that CA or SCA may inhibits the proliferation of vascular smooth muscle cell proliferation, as does natural or semi-synthetic polysaccharides, including Na-SP, heparin, 17) pentosan polysulfate 18) and fucoidan. 19) The present study was undertaken to examine this hypothesis using a culture system of bovine aortic smooth muscle cells. It was found that both CA and SCA moderately inhibit the proliferation of the cells without nonspecific cell damage. 2) (M r ca. 22000) containing sulfur of 13.4% were isolated from capsular Escherichia coli K1 as sodium salt of an a2,8-linked homopolymer of N-acetylneuraminic acid with or without sulfation. Na-SP and Ca-SP were isolated and purified from the blue-green alga Spirulina platensis as described previously. 10, 21, 22) Heparin derived from porcine intestine (M r ca. 10000) was purchased from Sigma (St Louis, MA, U.S.A.). Other reagents were from Nacalai Tesque (Kyoto, Japan).
MATERIALS AND METHODS

Materials
Morphological Procedure Vascular smooth muscle cells were cultured in DMEM supplemented with 10% fetal bovine serum in 100-mm dishes at 37°C in a humid atmosphere of 5% CO 2 until confluent. They were transferred into 24-well culture plates at 5ϫ10 3 cells/cm 2 and cultured for 24 h in DMEM supplemented with 10% fetal bovine serum. The cells were then incubated at 37°C for 24, 48 or 72 h in the presence of CA, SCA, Na-SP, Ca-SP or heparin (50 mg/ml each) in fresh DMEM supplemented with 10% fetal bovine serum. After treatment, the medium was discarded and the cells were stained with Giemsa.
Determination of Cell Number Vascular smooth muscle cells were plated into 24- 2 and then cultured for 24 h in DMEM supplemented with 10% fetal bovine serum in 6-well culture plates. The cells were treated with CA, SCA, Na-SP, Ca-SP or heparin (50 mg/ml each) in fresh DMEM supplemented with 10% fetal bovine serum, and labeled with [ 3 H]thymidine (20 kBq/ml) during the last 6 h of the treatment. After labeling, the medium was collected and used for the determination of lactate dehydrogenase activity as a marker of nonspecific cell damage. The cells were gently washed with CMF-PBS and harvested with a rubber policeman in the presence of CMF-PBS. Cell homogenate was prepared by sonication and incorporation of the radioactivity into 5% trichloroacetic acid-insoluble fraction of the cell homogenate was measured by liquid scintillation counting. A portion of the cell homogenate was used for the determination of DNA content by the fluorometric method 23) to express the incorporated radioactivity as dpm/mg DNA.
Statistical Analysis Data were analyzed for statistical significance by ANOVA and Bonferroni's multiple t-test when possible. p-Values of less than 0.05 were considered to indicate statistically significant differences. Figure 1 shows the morphological appearance of vascular smooth muscle cells after treatment with CA or SCA. Both CA and SCA (50 mg/ml each) inhibited the growth of the cells after 24 h and longer without any degenerative changes. In addition, the inhibitory effect of CA and SCA on the cell growth was not different in degree. Figure 2 shows the number of vascular smooth muscle cells after treatment with CA or SCA. Both CA and SCA at 25 mg/ml and more decreased the cell number in a dose-dependent manner. Time course study showed that the inhibition of cell growth occurred after 24 h and longer. These results agreed with the morphological observation showing a similar inhibitory effect of CA and SCA on vascular smooth muscle cells after 24 h and longer. Table 1 shows the incorporation of [ Since CA and SCA were shown to inhibit vascular smooth muscle cell proliferation in a similar degree, the inhibitory effect was compared with that of Na-SP, Ca-SP and heparin, known sulfated polysaccharides as inhibitors of the proliferation. Morphologically, it was shown that all polysaccharides (50 mg/ml each) inhibited the growth of vascular smooth muscle cells without any degenerative changes after a 48-h incubation (Fig. 3) ; a marked inhibition was observed in the cells treated with Na-SP and Ca-SP. When proliferative activity of the cells was evaluated by the [ 3 H]thymidine incorpo- 
RESULTS
control (24 h). B, CA treatment (24 h). C, SCA treatment (24 h). D, control (48 h). E, CA treatment (48 h). F, SCA treatment (48 h). G, control (72 h). H, CA treatment (72 h). I, SCA treatment (72 h)
. Giemsa stain (ϫ40). ration, it was shown that the inhibitory effect of Na-SP and Ca-SP was marked whereas that of CA, SCA and heparin was moderate (Fig. 4) .
DISCUSSION
Previously, it was indicated that Na-SP, Ca-SP, heparin and heparan sulfate inhibited the proliferation of vascular smooth muscle cells whereas dextran sulfate, dextran, chondroitin sulfate and dermatan sulfate did not show such an action, suggesting that inhibition of vascular smooth muscle cell proliferation is not a general activity of polysaccharide with or without sulfate groups. In the present study, we investigated the morphological change, the cell number, the [ Taking these results together, it is postulated that both CA and SCA inhibit the proliferation of vascular smooth muscle cells in a similar degree without nonspecific cell damage. Since the inhibitory effect of CA and SCA are weaker than that of Na-SP and Ca-SP but similar to that of heparin, it is likely that either CA or SCA can be an origin of agents that prevent atherosclerosis.
The inhibitory effect of Na-SP (Ca-SP) on vascular smooth muscle cell proliferation requires sulfate groups in their molecules. 11) In addition, the effects of Na-SP on vascular endothelial cell functions, including inhibition of the proliferation, 24) inhibition of the secretion of plasminogen activator inhibitor type 1 12) and stimulation of the release of proteoglycans, 13) disappear after desulfation. It has been shown that several biological activities of SCA also require the sulfate group. 2, [6] [7] [8] Thus, the sulfation appears to be in general essential for exhibition or intensification of the biological activities of polysaccharides. In contrast, the present data showed that the inhibitory effect of CA on vascular smooth muscle cell proliferation is unaffected by the sulfation, suggesting that the polysaccharide chain structure of CA interacts for itself with the cells and the sulfate group does not influence the interaction. However, the minimum chain length of CA required for inhibition of vascular smooth muscle cell proliferation remains to be elucidated.
Proliferation of vascular smooth muscle cells is largely influenced by growth factors that regulate the formation of extracellular matrix. For example, platelet-derived growth factor (PDGF) stimulates the proliferation of vascular smooth muscle cells in concert with increased synthesis of versican, a large chondroitin sulfate proteoglycan.
25) The proteoglycan interacts with hyaluronan and accumulates in the pericellular matrix when vascular smooth muscle cells proliferate and migrate.
26) The newly formed versican-hyaluronan-rich extracellular matrix allows the cells to prepare them for proliferation and migration. 27) In fact, inhibition of the versicanhyaluronan pericellular coat by short oligosaccharides of hyaluronan results in blocking PDGF-induced proliferation of vascular smooth muscle cells. 26) It is possible that CA and SCA may disturb the formation of the versican-hyaluronanrich extracellular matrix as does the short oligosaccharides of hyaluronan. In addition, the possibility that CA and SCA serve as a scavenger of autocrine growth factors, including PDGF, 28) fibroblast growth factors, 29) transforming growth factor-b 30) and tumor necrosis factor-a, 31) cannot be excluded.
In summary, the present data demonstrate that CA inhibits the proliferation of cultured vascular smooth muscle cells without inducing nonspecific cell damage. The inhibitory activity was not influenced by the sulfation. Recently, we found that CA strongly inhibits the proliferation of vascular endothelial cells and destroys the monolayer of the cells whereas SCA does not have such injurious activities (in preparation). SCA differs from CA, Na-SP and Ca-SP in that it inhibits the proliferation of vascular smooth muscle cells but not that of endothelial cells. Based on these results, further studies should be performed to clarify whether or not: helpful for the possible clinical application of CA and SCA to prevention of atherosclerosis.
